Research Topics
| Koji ObaSummaryAffiliation: Kyoto University Country: Japan Publications
| Collaborators
|
Detail Information
Publications
The domain structure of the EORTC QLQ-STO22 supported by Japanese validation dataSatoshi Morita
Health and Community Medicine Program, Nagoya University Graduate School of Medicine, Nagoya, Japan
Psychooncology 17:474-9. 2008..Extensive discussions with the EORTC Group are needed from both cross-cultural and clinical perspectives in order to establish a consensus on the various language versions of the QLQ-STO22...
Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysisKoji Oba
EBM Research Center, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
Int J Clin Oncol 14:85-9. 2009..It is expected to determine and quantify the role of adjuvant chemotherapy in detail from the GASTRIC...- Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancerKoji Oba
EBM Research Center, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Kyoto, Japan
Anticancer Res 29:2739-45. 2009..In the present study, the effect of immunochemotherapy with lentinan compared with that of chemotherapy alone was evaluated in patients with advanced gastric cancer through individual patient data (IPD) meta-analysis... - Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancerKoji Oba
Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto 606 8501, Japan
Cancer Immunol Immunother 56:905-11. 2007..7; P = 0.16]. The results of this meta-analysis suggest that adjuvant immunochemotherapy with PSK improves the survival of patients after curative gastric cancer resection... - Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials in JapanK Oba
Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
J Chemother 18:311-7. 2006..73 (95%CI=0.60-0.89). Our findings show that in Japan adjuvant chemotherapy using o-FP for long-term maintenance therapy appears to be effective for gastric cancer patients after curative resection... - Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trialKazuwa Nakao
Department of Medicine and Medical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
Hypertens Res 33:600-6. 2010..Candesartan treatment may suppress all-cause death and reduce the incidence of new-onset diabetes in patients with obesity... - Long-term effects of candesartan and amlodipine on cardiovascular mortality and morbidity in Japanese high-risk hypertensive patients: rationale, design, and characteristics of candesartan antihypertensive survival evaluation in Japan extension (CASE-J ExKenji Ueshima
EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
Contemp Clin Trials 30:97-101. 2009..CASE-J Ex will clarify the long-term effects of ARB and CCB on CV mortality and morbidity. Additionally, because the number of diabetic patients is increased, the evidences from CASE-J Ex will be valuable... - Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients. - Primary and secondary prevention of ischemic heart disease in a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) triaKenji Ueshima
EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
Circ J 75:2411-6. 2011..The aim of the present subanalysis was to evaluate the influence of coronary risk factors on coronary events in these patients as an observational study irrespective of allocated drugs... 
Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trialShinji Yasuno
EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
Diabetes Care 33:1122-7. 2010..Here, we examined the association between pulse pressure and the risk of new-onset diabetes in high-risk Japanese hypertensive patients...- Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trialShinji Yasuno
EBM Research Center, Kyoto University Graduate School of Medicine, Yoshida Konoecho, Sakyo ku, Kyoto 606 8501, Japan
J Hypertens 27:1705-12. 2009.... - Impact of left ventricular hypertrophy on the time-course of renal function in hypertensive patients – a subanalysis of the CASE-J trial –Kenji Ueshima
EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
Circ J 74:2132-8. 2010..In this subanalysis of the CASE-J, which was conducted to compare the effects of candesartan and amlodipine in Japanese high-risk hypertensive patients, THE ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY (LVH) WITH RENAL FUNCTION IS CLARIFIED... - Efficacy of oral anticancer agents for colorectal cancerJunichi Sakamoto
Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Kyoto, Japan
Dis Colon Rectum 49:S82-91. 2006 - Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trialsJunichi Sakamoto
Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Yoshidakonoe cho, Sakyo ku, Kyoto, 606 8501, Japan
Cancer Immunol Immunother 55:404-11. 2006..72 (95% CI: 0.58-0.90; P=0.003). The results of this meta-analysis suggest that adjuvant immunochemotherapy with PSK can improve both survival and disease-free survival of patients with curatively resected colorectal cancer... - Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphismsYusuke Okuyama
Department of Gastroenterology, Kyoto First Red Cross Hospital, Honmachi 15 749, Higashiyama ku, Kyoto, Japan
Jpn J Clin Oncol 41:477-82. 2011.... - Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in IranSaman Zamani
Department of Global Health and Socio Epidemiology, Kyoto University School of Public Health, Kyoto, Japan
J Urban Health 87:603-16. 2010..These study findings provide a behavioral profile of prisoners in regard to drug-related harm and can be considered in any plan to introduce or improve provision of MMT in prisons in Iran or other countries with similar features... - Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: subanalysis of the CASE-J trialKenji Ueshima
EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
Circ J 73:1080-5. 2009..The present study aimed to clarify the effect of cardiac complications on cardiovascular events in patients enrolled in CASE-J... - A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancerMichiya Kobayashi
Department of Tumor Surgery, Kochi Medical School, Kohasu, Japan
Gastric Cancer 9:114-9. 2006..These patients recovered and completed the scheduled treatment regimen. CONCLUSION: Sequential chemotherapy of paclitaxel and S-1 as postoperative adjuvant chemotherapy for advanced gastric cancer is feasible... - A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study groupHaruhiko Cho
Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1 1 2, Nakao, Asahi ku, Yokohama 2410815, Japan
Jpn J Clin Oncol 38:71-3. 2008..The sample size is 86 (43 for surgery alone and 43 for exercise group) to select promising treatment for Phase III trial in a randomized Phase II setting... - Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in JapanMichiya Kobayashi
Department of Human Health and Medical Sciences, Kochi Medical School, Oko cho, Nankoku, 783 8505, Japan
Gastric Cancer 10:52-7. 2007..We aimed to clarify the relationship between the maximum tolerated dose and plasma concentration of paclitaxel in Japanese patients with gastric cancer on a weekly paclitaxel administration regimen...